An In Silico Platform to Predict Cardiotoxicity Risk of Anti-tumor Drug Combination with hiPSC-CMs Based In Vitro Study.

MLA

Sang, Lan, et al. “An In Silico Platform to Predict Cardiotoxicity Risk of Anti-Tumor Drug Combination with HiPSC-CMs Based In Vitro Study.” Pharmaceutical Research, vol. 41, no. 2, Feb. 2024, pp. 247–62. EBSCOhost, https://doi.org/10.1007/s11095-023-03644-4.

APA

Sang, L., Zhou, Z., Luo, S., Zhang, Y., Qian, H., Zhou, Y., He, H., & Hao, K. (2024). An In Silico Platform to Predict Cardiotoxicity Risk of Anti-tumor Drug Combination with hiPSC-CMs Based In Vitro Study. Pharmaceutical Research, 41(2), 247–262. https://doi.org/10.1007/s11095-023-03644-4

Chicago

Sang, Lan, Zhengying Zhou, Shizheng Luo, Yicui Zhang, Hongjie Qian, Ying Zhou, Hua He, and Kun Hao. 2024. “An In Silico Platform to Predict Cardiotoxicity Risk of Anti-Tumor Drug Combination with HiPSC-CMs Based In Vitro Study.” Pharmaceutical Research 41 (2): 247–62. doi:10.1007/s11095-023-03644-4.